Liu X - Search Results

1

Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries.

Jing L, Wu G, Hao X, Olotu FA, Kang D, Chen CH, Lee KH, Soliman MES, Liu X, Song Y, Zhan P. Jing L, et al. Among authors: liu x. Eur J Med Chem. 2019 Dec 1;183:111696. doi: 10.1016/j.ejmech.2019.111696. Epub 2019 Sep 14. Eur J Med Chem. 2019. PMID: 31541869

2

Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs).

Lin Y, Liu X, Yan R, Li J, Pannecouque C, Witvrouw M, De Clercq E. Lin Y, et al. Among authors: liu x. Bioorg Med Chem. 2008 Jan 1;16(1):157-63. doi: 10.1016/j.bmc.2007.10.013. Epub 2007 Oct 10. Bioorg Med Chem. 2008. PMID: 17964796 Free article.

3

Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.

Liu XY, Yan RZ, Wang Y, Zhan P, De Clercq E, Pannecouque C, Witvrouw M, Molina MT, Vega S. Liu XY, et al. Arch Pharm (Weinheim). 2008 Apr;341(4):216-22. doi: 10.1002/ardp.200700216. Arch Pharm (Weinheim). 2008. PMID: 18266290

4

Recent advances in antiviral activity of benzo/heterothiadiazine dioxide derivatives.

Zhan P, Liu X, De Clercq E. Zhan P, et al. Among authors: liu x. Curr Med Chem. 2008;15(15):1529-40. doi: 10.2174/092986708784638898. Curr Med Chem. 2008. PMID: 18537628 Review.

5

1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

Zhan P, Liu X, Cao Y, Wang Y, Pannecouque C, De Clercq E. Zhan P, et al. Among authors: liu x. Bioorg Med Chem Lett. 2008 Oct 15;18(20):5368-71. doi: 10.1016/j.bmcl.2008.09.055. Epub 2008 Sep 18. Bioorg Med Chem Lett. 2008. PMID: 18824350

6

Recent advances in the research of HIV-1 RNase H inhibitors.

Yu F, Liu X, Zhan P, De Clercq E. Yu F, et al. Among authors: liu x. Mini Rev Med Chem. 2008 Oct;8(12):1243-51. doi: 10.2174/138955708786141052. Mini Rev Med Chem. 2008. PMID: 18855738 Review.

7

Ligustrazine derivatives. Part 3: Design, synthesis and evaluation of novel acylpiperazinyl derivatives as potential cerebrocardiac vascular agents.

Cheng XC, Liu XY, Xu WF, Guo XL, Zhang N, Song YN. Cheng XC, et al. Bioorg Med Chem. 2009 Apr 15;17(8):3018-24. doi: 10.1016/j.bmc.2009.03.012. Epub 2009 Mar 13. Bioorg Med Chem. 2009. PMID: 19329327

8

Capsid (CA) protein as a novel drug target: recent progress in the research of HIV-1 CA inhibitors.

Zhang J, Liu X, De Clercq E. Zhang J, et al. Among authors: liu x. Mini Rev Med Chem. 2009 Apr;9(4):510-8. doi: 10.2174/138955709787847958. Mini Rev Med Chem. 2009. PMID: 19356128 Review.

9

Designed multiple ligands: an emerging anti-HIV drug discovery paradigm.

Zhan P, Liu X. Zhan P, et al. Among authors: liu x. Curr Pharm Des. 2009;15(16):1893-917. doi: 10.2174/138161209788453266. Curr Pharm Des. 2009. PMID: 19519431 Review.

10

Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIs.

Zhan P, Li Z, Liu X, De Clercq E. Zhan P, et al. Among authors: liu x. Mini Rev Med Chem. 2009 Jul;9(8):1014-23. doi: 10.2174/138955709788681618. Mini Rev Med Chem. 2009. PMID: 19601897 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136,659 results

Search Page

Filters